Sinovac’s Panflu Is First Chinese Avian Flu Vaccine Approved By SFDA
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Sinovac Biotech has been granted a production license for its pandemic influenza vaccine Panflu from China's State FDA, the company announced April 2. Panflu is the first vaccine approved since SFDA implemented its Special Drug Approval Procedures in 2005